David Segev

518 total citations
17 papers, 386 citations indexed

About

David Segev is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Segev has authored 17 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Segev's work include Vitamin D Research Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Biotin and Related Studies (2 papers). David Segev is often cited by papers focused on Vitamin D Research Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Biotin and Related Studies (2 papers). David Segev collaborates with scholars based in Israel, Canada and United States. David Segev's co-authors include S. Braverman, Glenville Jones, Yehuda Mazur, Doron Hermoni, Michael Lishner, Shabtai Varsano, David Shitrit, Avi Leader, Avishay Elis and Morris Mosseri and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

In The Last Decade

David Segev

17 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Segev Israel 10 101 82 82 62 56 17 386
L.G. Alcindor France 12 19 0.2× 37 0.5× 63 0.8× 63 1.0× 52 0.9× 32 351
W. F. A. Grose Netherlands 10 22 0.2× 49 0.6× 91 1.1× 39 0.6× 33 0.6× 14 340
R Preisig Switzerland 12 20 0.2× 33 0.4× 35 0.4× 77 1.2× 89 1.6× 24 468
S.A. Iversen United Kingdom 7 41 0.4× 91 1.1× 24 0.3× 9 0.1× 100 1.8× 11 389
Chengxiao Zhao China 7 14 0.1× 100 1.2× 36 0.4× 19 0.3× 85 1.5× 15 300
Sean Tighe United States 13 15 0.1× 56 0.7× 97 1.2× 26 0.4× 56 1.0× 18 565
F. Lemonnier France 12 36 0.4× 17 0.2× 31 0.4× 82 1.3× 103 1.8× 27 521
P. Cawood United Kingdom 8 41 0.4× 92 1.1× 28 0.3× 12 0.2× 89 1.6× 8 494
Alicia Batchelor United States 7 6 0.1× 82 1.0× 44 0.5× 31 0.5× 31 0.6× 10 324
Jeffrey Nadelson United States 10 81 0.8× 19 0.2× 59 0.7× 12 0.2× 67 1.2× 16 319

Countries citing papers authored by David Segev

Since Specialization
Citations

This map shows the geographic impact of David Segev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Segev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Segev more than expected).

Fields of papers citing papers by David Segev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Segev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Segev. The network helps show where David Segev may publish in the future.

Co-authorship network of co-authors of David Segev

This figure shows the co-authorship network connecting the top 25 collaborators of David Segev. A scholar is included among the top collaborators of David Segev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Segev. David Segev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kalter‐Leibovici, Ofra, Michal Benderly, Laurence S. Freedman, et al.. (2018). Disease Management plus Recommended Care versus Recommended Care Alone for Ambulatory Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 197(12). 1565–1574. 10 indexed citations
2.
Varsano, Shabtai, David Segev, & David Shitrit. (2016). Severe and non-severe asthma in the community: A large electronic database analysis. Respiratory Medicine. 123. 131–139. 25 indexed citations
3.
Leader, Avi, et al.. (2014). Thyrotropin Levels Within the Lower Normal Range Are Associated With an Increased Risk of Hip Fractures in Euthyroid Women, But Not Men, Over the Age of 65 Years. The Journal of Clinical Endocrinology & Metabolism. 99(8). 2665–2673. 42 indexed citations
4.
Elis, Avishay, Yoram Neuman, Morris Mosseri, et al.. (2013). Lipid control in patients with coronary heart disease treated in primary care or cardiology clinics. Journal of clinical lipidology. 7(6). 637–641. 3 indexed citations
5.
Pereg, David, Avishay Elis, Yoram Neuman, et al.. (2013). Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention. Coronary Artery Disease. 25(1). 79–82. 8 indexed citations
6.
Pereg, David, Yoram Neuman, Avishay Elis, et al.. (2012). Comparison of Lipid Control in Patients With Coronary Versus Peripheral Artery Disease Following the First Vascular Intervention. The American Journal of Cardiology. 110(9). 1266–1269. 6 indexed citations
7.
Tirosh, Amir, Avishay Elis, Yoram Neuman, et al.. (2012). Mortality and Coronary Heart Disease in Euthyroid Patients. The American Journal of Medicine. 125(8). 826.e7–826.e12. 27 indexed citations
8.
Elis, Avishay, David Pereg, Paul Froom, et al.. (2011). HDL‐C Levels and Revascularization Procedures in Coronary Heart Disease Patients Treated With Statins to Target LDL‐C Levels. Clinical Cardiology. 34(9). 572–576. 1 indexed citations
9.
Peer, Gary, Yoram Wollman, Tamara Chernihovsky, et al.. (2001). Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension. Nephrology Dialysis Transplantation. 16(7). 1436–1441. 24 indexed citations
10.
Segev, David, Oded Szold, Elizabeth Fireman, Yoram Kluger, & Patrick Sorkine. (1999). Kerosene-induced severe acute respiratory failure in near drowning. Critical Care Medicine. 27(8). 1437–1440. 20 indexed citations
11.
Goldstein, Itamar, et al.. (1997). Very Early Onset of Acute Amiodarone Pulmonary Toxicity Presenting With Hemoptysis. CHEST Journal. 111(5). 1446–1447. 22 indexed citations
12.
Carpino, Louis A., et al.. (1989). Thioxanthene dioxide based amino-protecting groups sensitive to pyridine bases and dipolar aprotic solvents. The Journal of Organic Chemistry. 54(25). 5887–5897. 8 indexed citations
13.
Chernajovsky, Yuti, et al.. (1983). Production of Human Interferon in E. coli Under lac and tryplac Promoter Control. Annals of the New York Academy of Sciences. 413(1). 88–96. 9 indexed citations
14.
Jones, Glenville, et al.. (1980). Displacement Potency of Vitamm D2Analogs in Competitive Protein-Binding Assays for 25– Hydroxyvitamin D3, 24,25–Dihydroxyvitamin D3, and 1,25–Dihydroxyvitamin D3. The Journal of Clinical Endocrinology & Metabolism. 50(4). 773–775. 59 indexed citations
15.
Jones, Glenville, David Segev, Yehuda Mazur, et al.. (1979). Isolation and identification of 24,25-dihydroxy vitamin D2 by use of the perfused rat kidney. Biochemistry. 18(6). 1094–1101. 18 indexed citations
16.
Jones, Glenville, David Segev, Yehuda Mazur, et al.. (1979). 24(R), 25-dihydroxyvitamin D2 synthesis, determination of absolute configuration by x-ray analysis and identification as a kidney metabolite of vitamin D2. Tetrahedron Letters. 20(2). 177–180. 6 indexed citations
17.
Braverman, S. & David Segev. (1974). Novel cyclization of diallenic sulfones. Journal of the American Chemical Society. 96(4). 1245–1247. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026